DI BARI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 695
EU - Europa 223
AS - Asia 93
AF - Africa 7
SA - Sud America 2
Totale 1.020
Nazione #
US - Stati Uniti d'America 693
IT - Italia 125
SG - Singapore 34
IN - India 32
SE - Svezia 32
FI - Finlandia 25
CN - Cina 23
BG - Bulgaria 8
DE - Germania 7
GB - Regno Unito 6
TG - Togo 5
ID - Indonesia 4
RO - Romania 4
UA - Ucraina 4
FR - Francia 3
IE - Irlanda 3
BE - Belgio 2
CA - Canada 2
NL - Olanda 2
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ES - Italia 1
ZA - Sudafrica 1
Totale 1.020
Città #
Fairfield 148
Ashburn 74
Rome 59
Woodbridge 58
Houston 54
Seattle 44
Cambridge 39
Wilmington 31
Fasano 30
Singapore 30
Chandler 26
Tappahannock 19
Beijing 18
Princeton 18
San Paolo di Civitate 16
Plano 15
Helsinki 13
Santa Clara 13
Lawrence 12
Ann Arbor 9
Boston 8
Sofia 8
Washington 8
Millbury 7
San Diego 7
Cagliari 6
Andover 5
Dearborn 5
Lomé 5
Jakarta 4
New York 4
Dublin 3
Norwalk 3
Phoenix 3
Bari 2
Brussels 2
Bühl 2
Cluj-napoca 2
Palermo 2
Pune 2
Toronto 2
Vado Ligure 2
Abidjan 1
Amsterdam 1
Berlin 1
Bern 1
Bremen 1
Chaoyang 1
Chengdu 1
Chieti 1
Derio 1
Des Moines 1
Falls Church 1
Federal 1
Fremont 1
Grafing 1
Jacksonville 1
Jinan 1
Kunming 1
London 1
Los Angeles 1
Muizenberg 1
Munich 1
Nanjing 1
Prescot 1
Provo 1
Redmond 1
San Mateo 1
Stockholm 1
São Paulo 1
Totale 846
Nome #
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients 99
Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation 90
The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells 88
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 87
M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines 84
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype 83
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: Implication in peripheral inflammation 81
Cholinergic system and neuroinflammation: implication in multiple sclerosis 71
M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells 71
Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells 66
M2 MUSCARINIC RECEPTORS INHIBIT CELL PROLIFERATION AND MIGRATION IN UROTHELIAL BLADDER CANCER CELLS 59
Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phase 57
Cytostatic and cytotoxic effects induced by M2 muscarinic receptor activation on human glioblastoma cells 34
null 32
Role of muscarinic receptors in tumors: possible therapeutic implications 31
CYTOSTATIC AND CYTOTOXIC EFFECTS INDUCED BY M2 MUSCARINIC RECEPTOR ACTIVATION ON HUMAN GLIOBLASTOMA CELL LINES 28
Inflammatory cytokines and cholinergic system dis-function in multiple sclerosis patients. 9
Totale 1.070
Categoria #
all - tutte 3.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020180 0 0 0 0 27 26 31 26 25 22 15 8
2020/2021119 7 9 39 3 1 3 2 14 8 19 9 5
2021/2022171 0 7 35 4 18 2 16 22 9 11 20 27
2022/2023143 32 43 9 12 9 8 3 6 9 0 7 5
2023/2024112 8 11 8 14 10 17 3 24 2 7 2 6
2024/202547 8 3 3 7 26 0 0 0 0 0 0 0
Totale 1.070